Analysts did not seem very concerned by the treatment-related serious adverse event, noting that NGN-401 was well-tolerated ...
Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) today. The ...
ATA-200 is a one-time gene therapy for the treatment of γ-sarcoglycan related ... a single-dose Adeno-Associated Virus (AAV) vector carrying the human γ-sarcoglycan transgene. The deployment in the US ...
The fully equipped lab features high-end pilot-scale equipment, enabling DINAMIQS to provide clinical viral vector development, analytical and manufacturing services to meet the growing needs of the ...
REMAIN-1 weight maintenance pivotal study enrollment progressing rapidly; mid-point data analysis expected in Q2 2025 ...
Ascend’s fill/finish capacity in the US will also be expanded. “We founded Ascend with a vision to quilt together the best operators and technologies within the advanced manufacturing field. The ...
This study presents a valuable finding on the molecular mechanisms that govern GABAergic inhibitory synapse function. The authors propose that Endophilin A1 serves as a novel regulator of GABAergic ...
Investor's Business Daily on MSN6h
Top Biotech Neurogene Crashes 44%, Wiping Out Its Sprint On A $200 Million DealBiotech stock Neurogene collapsed Tuesday after a patient experienced a serious side effect in the company's Rett syndrome ...
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the launch of its new Global Therapy Innovations business unit, designed to integrate disease expertise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback